Intuitive Surgical, Inc. $ISRG Stock Purchased by Daytona Street Capital LLC

Daytona Street Capital LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 657.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,845 shares of the medical equipment provider’s stock after purchasing an additional 6,809 shares during the period. Intuitive Surgical accounts for approximately 2.1% of Daytona Street Capital LLC’s investment portfolio, making the stock its 9th biggest position. Daytona Street Capital LLC’s holdings in Intuitive Surgical were worth $3,177,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. Walser Wealth Management Company A Ltd Liability Co lifted its position in Intuitive Surgical by 61.8% during the third quarter. Walser Wealth Management Company A Ltd Liability Co now owns 1,306 shares of the medical equipment provider’s stock worth $531,000 after acquiring an additional 499 shares during the last quarter. V Square Quantitative Management LLC boosted its holdings in shares of Intuitive Surgical by 13.7% during the third quarter. V Square Quantitative Management LLC now owns 3,735 shares of the medical equipment provider’s stock worth $1,519,000 after acquiring an additional 450 shares during the period. Davidson Capital Management Inc. boosted its holdings in shares of Intuitive Surgical by 29.6% during the third quarter. Davidson Capital Management Inc. now owns 4,777 shares of the medical equipment provider’s stock worth $1,942,000 after acquiring an additional 1,092 shares during the period. Assenagon Asset Management S.A. grew its position in shares of Intuitive Surgical by 55.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after purchasing an additional 558,099 shares during the last quarter. Finally, WealthPLAN Partners LLC grew its position in shares of Intuitive Surgical by 18.5% in the third quarter. WealthPLAN Partners LLC now owns 640 shares of the medical equipment provider’s stock valued at $260,000 after purchasing an additional 100 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ISRG. TD Cowen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Oppenheimer upgraded Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 price target for the company in a research note on Wednesday, August 12th. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Piper Sandler reaffirmed an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $498.83.

Intuitive Surgical Stock Up 1.8%

Shares of Intuitive Surgical stock opened at $427.86 on Friday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The company has a 50-day simple moving average of $390.47 and a two-hundred day simple moving average of $409.62. The stock has a market capitalization of $151.15 billion, a price-to-earnings ratio of 49.01, a price-to-earnings-growth ratio of 3.17 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the previous year, the firm posted $1.81 EPS. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical outperformed the broader market in the latest session, supported by its long-term growth profile and investor interest ahead of earnings. The company’s most recent quarterly results also showed strong momentum, with earnings and revenue exceeding analyst expectations and revenue rising 18.4% year over year. Intuitive Surgical Beats Stock Market Upswing
• Positive Sentiment: Analysts are watching da Vinci 5 adoption, Ion procedures, surgical-system placements and recurring instrument and accessory revenue as potential indicators of another strong quarter. These operating metrics could provide more insight than revenue and earnings per share alone. Countdown to Intuitive Surgical Q3 Earnings
• Positive Sentiment: Erste Group Bank marginally raised its fiscal 2026 earnings forecast to $8.94 per share, above the approximately $8.87 consensus estimate, signaling modestly improved expectations for profitability.
• Neutral Sentiment: Intuitive Surgical has gained nearly 12% over the past month, making the upcoming earnings release an important catalyst for whether the recent rally can continue. Analysts also highlight the company as a sales-growth stock, with strong projected revenue expansion for 2026. ISRG Gains Nearly 12% in a Month
• Negative Sentiment: Valuation remains a concern: ISRG trades at roughly 49 times earnings, and one analysis estimates the shares could be about 31% overvalued even after an improved earnings outlook. Any weaker-than-expected Q3 metrics or cautious guidance could pressure the stock. Intuitive Surgical Could Be 31% Overvalued

Insider Activity at Intuitive Surgical

In other news, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the sale, the executive vice president directly owned 881 shares in the company, valued at approximately $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.